Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun 15;205(12):1379-1381.
doi: 10.1164/rccm.202202-0301ED.

Drug Therapy for Obstructive Sleep Apnea: Are We There Yet?

Christopher N Schmickl  1 , Bradley A Edwards  2   3 , Atul Malhotra  1
Affiliations
Editorial

Drug Therapy for Obstructive Sleep Apnea: Are We There Yet?

Christopher N Schmickl et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet . 2014;383:736–747. - PMC - PubMed
    1. Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A. Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med . 2013;188:996–1004. - PMC - PubMed
    1. Schmickl CN, Owens RL, Edwards BA, Malhotra A. OSA endotypes: what are they and what are their potential clinical implications? Curr Sleep Med Rep . 2018;4:231–242.
    1. Pépin JL, Bailly S, Rinder P, Adler D, Szeftel D, Malhotra A, et al. On Behalf of the medXcloud Group CPAP therapy termination rates by OSA phenotype: a French nationwide database analysis. J Clin Med . 2021;10:936. - PMC - PubMed
    1. Taranto-Montemurro L, Messineo L, Sands SA, Azarbarzin A, Marques M, Edwards BA, et al. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity: a randomized, placebo-controlled, double-blind crossover trial. Am J Respir Crit Care Med . 2019;199:1267–1276. - PMC - PubMed

MeSH terms